News for Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics, Inc. (NASDAQ:TVTX) is among the 10 Best Growth Stocks Under $100 to Buy Now.

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Travere Therapeutics, Inc. (”œTravere” or the

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced the launch of a new awareness campaign, ”œPlay It Forward,” to bring hope and encouragement to the

Travere Therapeutics (TVTX) launches "Play It Forward" campaign on the first-ever FSGS Awareness Day. Grammy-winning producer Brian Kennedy and artist D

PR NewswireNEW YORK, June 7, 2025 NEW YORK, June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Travere Therapeuti

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Travere Therapeutics, Inc. (”œTravere” or the

Summary Travere Therapeutics Inc (TVTX) announced its participation in the upcoming European Renal Association (ERA) Congress in Vienna, Austria, from June 4-7,

Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present seven abstracts at the upcoming European Renal Association (ERA) Congr

Travere Therapeutics to present new FILSPARI® (sparsentan) data at the 62nd European Renal Association Congress (ERA) in Vienna. Significant findings i

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Travere Therapeutics, Inc. (”œTravere” or the

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Travere Therapeutics, Inc. (”œTravere” or the â

**media[633082]**

PR NewswireNEW YORK, May 20, 2025 NEW YORK, May 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Travere Therapeuti

Travere Therapeutics stock did suffer a bit of setback last week as the FDA moved back the anticipated decision date on a recently submitted sNDA. Read the latest analysis here.

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday. Shares of Globant S.A. GLOB fell sharply in today's pre-...

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Texas-based TSS, Inc. (TSSI) is up over 43 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Travere Therapeutics (TVTX) experienced a significant decline in its stock price, dropping 14% to $18.10. This downturn followed the U.S. Food and Drug Administ

Travere Therapeutics (TVTX) witnessed a selloff after it was announced that the FDA would conduct a standard review, rather than a priority review, for the comp